ASHLEY CREMISIO: Open Payments
NPI 1811536543 · FREDERICKSBRG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 48 payments from 9 companies in 2025. Trend: 2023 $244 · 2024 $512 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $438 |
| AstraZeneca Pharmaceuticals LP | 3 | $226 |
| Novo Nordisk Inc | 5 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $64 |
| Amgen Inc. | 3 | $58 |
| PFIZER INC. | 2 | $48 |
| Lilly USA, LLC | 2 | $39 |
| Exact Sciences Corporation | 1 | $24 |
| Lundbeck LLC | 1 | $15 |
Products named: QULIPTA, Wegovy, VRAYLAR, BREZTRI, TEZSPIRE, UBRELVY, CAPLYTA, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
